National Bank of Canada
MGNX icon

National Bank of Canada’s MacroGenics MGNX Stock Holding History

National Bank of Canada’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-190
Closed -$241 – 3144
2025
Q1 		$241 Sell
190
-1,000
-84% -$2.61K ﹤0.01% 2683
2024
Q4 		$3.87K Buy
1,190
+593
+99% +$2.14K ﹤0.01% 2481
2024
Q3 		$1.96K Sell
597
-4,593
-88% -$17.9K ﹤0.01% 2358
2024
Q2 		$22.2K Buy
5,190
+4,000
+336% +$39K ﹤0.01% 1939
2024
Q1 		$3.94K Buy
1,190
+1,000
+526% +$15.1K ﹤0.01% 2353
2023
Q4 		$1.93K Hold
190
– – ﹤0.01% 2461
2023
Q3 		$849 Hold
190
– – ﹤0.01% 2605
2023
Q2 		$1.01K Buy
+190
New +$1.17K ﹤0.01% 2554

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

National Bank of Canada's MGNX Position: Q2 2025 in Review

National Bank of Canada sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 190 shares — an estimated $241 sold.

National Bank of Canada first reported a position in MGNX in Q2 2023 and held it in 8 quarters. The position peaked at $22.2K in Q2 2024. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • National Bank of Canada reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • National Bank of Canada sold 190 MacroGenics shares in Q2 2025, an estimated $241.
  • National Bank of Canada first reported a position in MacroGenics in Q2 2023 and held it in 8 quarters.
  • National Bank of Canada's MacroGenics position peaked at $22.2K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.